Corvus Pharmaceuticals Inc. (CRVS) at a glance

Corvus Pharmaceuticals Inc. (CRVS) is a small-cap Healthcare company. It trades at $14.1, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Safety (76/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$14.10

Market cap

$1.00B

P/E ratio

n/a

Dividend yield

None

Beta

0.84

52-week range

$5.28 to $26.95